MURRAY HILL, N.J.--(HSMN NewsFeed)--C. R. Bard, Inc. (NYSE: BCR ) today announced that it has closed the previously announced acquisition of the assets of the LifeStent® product family from Edwards Lifesciences Corporation, headquartered in Irvine, California. Bard will immediately commence marketing the products globally.
full article >> http://salesandmarketingnetwork.com/news_release.php?ID=2022671
Monday, January 14, 2008
Bard Closes Transaction to Acquire LifeStent(R) from Edwards Lifesciences
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment